General Updates

Ref: ADL/SE/2026-27/51 October 1, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai – 400051 BSE CODE: 524348 NSE SYMBOL: AARTIDRUGS Dear Sir/Madam, Ref: Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sub: Details of Authorized Persons under Regulation 30(5) of the SEBI LODR Regulations, 2015 Pursuant to Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and consequent to the recent changes in the Directorate/ Management of the Company, we hereby inform that, with effect from October 1, 2026, the following persons shall be authorized for the purpose of determining materiality of an event or information and making disclosures to Stock Exchanges: Sr. Name and designation Contact details Authorized to 1. Shri Adhish P. Patil, mgnt@aartidrugs.com Determine materiality Managing Director of an event or information and 2. Shri Harshit M. Savla, mgnt@aartidrugs.com making disclosure to Jt. Managing Director Stock Exchange. 3. Rushikesh V. Deole, investorrelations@aartidrugs.com Making disclosure to Company Secretary and Stock Exchange. Compliance Officer The aforesaid information is also being made available on the Company's website at https://www.aartidrugs.com/ Kindly take the same on record. Thanking you Yours faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M. No.: F12932